We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+10.23%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$43B
AUM Growth
+$121M
(+0.28%)
Cap. Flow
-$3.21B
Cap. Flow
% of AUM
-7.47%
Top 10 Holdings %
Top 10 Hldgs %
18.86%
Holding
2,029
New
505
Increased
717
Reduced
446
Closed
331
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$285M |
| 2 |
Applied Materials
AMAT
|
+$234M |
| 3 |
Micron Technology
MU
|
+$185M |
| 4 |
Merck
MRK
|
+$161M |
| 5 |
NXP Semiconductors
NXPI
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$505M |
| 2 |
Bank of America
BAC
|
+$339M |
| 3 |
Nike
NKE
|
+$335M |
| 4 |
Union Pacific
UNP
|
+$329M |
| 5 |
Citigroup
C
|
+$277M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.49% |
| 2 | Financials | 16.82% |
| 3 | Consumer Discretionary | 16.55% |
| 4 | Healthcare | 14.39% |
| 5 | Industrials | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
OFS Capital
OFS
$51.9M
| $770K | ﹤0.01% |
68,954
-112,384
| -62% | -$1.3M |
|
|
SACH
1402
Sachem Capital Corp
SACH
$39.8M
| $768K | ﹤0.01% |
176,990
-75,661
| -30% | -$338K |
|
1403
Cytokinetics
CYTK
$10.4B
| $765K | ﹤0.01% |
+72,100
| New | +$741K |
|
1404
Sabra Healthcare REIT
SBRA
$5.37B
| $764K | ﹤0.01% |
+35,800
| New | +$802K |
|
1405
Gorman-Rupp
GRC
$2.21B
| $763K | ﹤0.01% |
20,353
+7,253
| +55% | +$264K |
|
1406
OceanFirst Financial
OCFC
$1.91B
| $760K | ﹤0.01% |
29,745
+15,545
| +109% | +$374K |
|
1407
Banco Santander Chile
BSAC
$16.6B
| $756K | ﹤0.01% |
+32,769
| New | +$815K |
|
1408
Arrow Financial
AROW
$652M
| $753K | ﹤0.01% |
+22,430
| New | +$706K |
|
|
LBAI
1409
DELISTED
Lakeland Bancorp Inc
LBAI
| $751K | ﹤0.01% |
43,193
-10,010
| -19% | -$165K |
|
1410
AngioDynamics
ANGO
$649M
| $749K | ﹤0.01% |
46,754
+35,542
| +317% | +$543K |
|
|
AVID
1411
DELISTED
Avid Technology Inc
AVID
| $748K | ﹤0.01% |
+87,196
| New | +$642K |
|
1412
Coda Octopus Group
CODA
$120M
| $745K | ﹤0.01% |
88,970
-25,671
| -22% | -$196K |
|
1413
MasterCraft Boat Holdings
MCFT
$590M
| $743K | ﹤0.01% |
47,193
-207,596
| -81% | -$3.27M |
|
1414
Smart Sand
SND
$194M
| $741K | ﹤0.01% |
293,910
-71,016
| -19% | -$176K |
|
1415
Omnicom Group
OMC
$23.4B
| $737K | ﹤0.01% |
+9,100
| New | +$713K |
|
1416
Sasol
SSL
$7.1B
| $737K | ﹤0.01% |
34,090
-270,128
| -89% | -$5.17M |
|
1417
Bristow Group
VTOL
$1.36B
| $736K | ﹤0.01% |
+36,200
| New | +$717K |
|
|
RST
1418
DELISTED
ROSETTA STONE INC
RST
| $731K | ﹤0.01% |
+40,300
| New | +$687K |
|
|
IO
1419
DELISTED
ION Geophysical Corporation
IO
| $720K | ﹤0.01% |
+82,990
| New | +$718K |
|
1420
Travelzoo
TZOO
$75.4M
| $719K | ﹤0.01% |
67,176
-2,767
| -4% | -$28.7K |
|
|
HAYN
1421
DELISTED
Haynes International, Inc.
HAYN
| $716K | ﹤0.01% |
+20,000
| New | +$721K |
|
1422
American Electric Power
AEP
$68.4B
| $699K | ﹤0.01% |
+7,400
| New | +$684K |
|
|
PBFX
1423
DELISTED
PBF LOGISTICS LP
PBFX
| $699K | ﹤0.01% |
+34,542
| New | +$721K |
|
1424
First Solar
FSLR
$26.9B
| $694K | ﹤0.01% |
12,400
+6,400
| +107% | +$351K |
|
|
OSG
1425
DELISTED
Overseas Shipholding Group Inc.
OSG
| $694K | ﹤0.01% |
301,858
+148,357
| +97% | +$276K |
|
Similar funds
VGA
Arrowstreet Capital's Q4 2019 Portfolio in Review
As of Q4 2019, Arrowstreet Capital held 2,029 positions worth $43B, up 0.28% from $42.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Arrowstreet Capital withdrew a net $3.21B in Q4 2019, closing 331 positions and reducing 446 holdings. Its most notable exit was Celgene Corp, an estimated $505M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Arrowstreet Capital opened a new position in Edwards Lifesciences worth $127M.
- Arrowstreet Capital's largest Q4 2019 buy was Edwards Lifesciences: 1,637,208 shares worth $127M.
- Arrowstreet Capital added most to Intel in Q4 2019, an estimated $285M increase.
- Arrowstreet Capital's biggest Q4 2019 reduction was Union Pacific, cutting an estimated $329M.
- Arrowstreet Capital fully exited Celgene Corp in Q4 2019, selling an estimated $505M.
- Arrowstreet Capital's ten largest holdings make up 19% of its $43B portfolio in Q4 2019.
- Arrowstreet Capital opened 505 new positions and closed 331 in Q4 2019.
- Arrowstreet Capital's portfolio value rose 0.28% quarter-over-quarter to $43B.
Based on Arrowstreet Capital's 13F filing for Q4 2019, filed 13 Feb 2020.